Showing results (231-240 of 385) with videos related to

Sort By:
Pageof 39
European Urology|June 9, 2004
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patientsAlexandre R Zlotta, Thierry Roumeguère, Vincent Ravery, et al.
Radiology|July 19, 2022
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive MenSangeet Ghai, Nathan Perlis, Chantal Atallah, et al.
Lancet Regional Health. Americas|October 3, 2025
Is it time for Canada to revisit its approach to prostate cancer screening?David-Dan Nguyen, Aisha Lofters, Christopher J D Wallis, et al.
The Journal of Urology|April 19, 2014
Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progressionLih-Ming Wong, Ants Toi, Theodorus Van der Kwast, et al.
Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Biopreservation and Biobanking|October 25, 2023
Biospecimen Qualification in a Clinical Biobank of Urological DiseasesOlga Kofanova, Sangita Paul, Achilleas Pexaras, et al.
The Journal of Urology|November 28, 2017
Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative EffectNathan Perlis, Thamir Al-Kasab, Ardalan Ahmad, et al.
BJU International|December 22, 2004
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam, Ants Toi, John Trachtenberg, et al.
Urologic Oncology|May 10, 2022
Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomesYazan Qaoud, Jaime O Herrera-Caceres, Roman Bass, et al.
Pageof 39